Skip to main content
    C

    Crocs Inc (CROX)

    Official site

    CONSUMER CYCLICAL • FOOTWEAR & ACCESSORIES • NASDAQ

    $124.77
    +7.23 (+6.15%)

    Market Cap: $5.98B

    Last updated: Oct 16, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    92%(36/39)
    Avg Surprise
    +48.25%
    Streak
    25 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$3.30
    Range$3.25 - $3.37
    14 analysts
    EPS RevisionsNo revisions (7d)
    0
    13
    30d
    EPS Estimate DriftChange to current
    90d ago$3.55-6.9%
    60d ago$3.30+0.0%
    30d ago$3.300.0%
    7d ago$3.300.0%
    Current$3.30
    Revenue Consensus
    $1.0B
    Range$996M - $1.0B
    12 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.53
    Range$3.33 - $3.75
    15 analysts
    Revenue Consensus
    $1.0B
    Range$1.0B - $1.1B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.53---
    Sep 26EST
    		-$3.30---
    Jun 26
    Reported Jul 30
    		$4.55$4.32+5.32%Beat+7.6%
    Mar 26
    Reported Apr 30
    		$2.99$2.79+7.17%Beat-0.3%
    Dec 25
    Reported Feb 12
    		$2.29$1.91+19.90%Beat-9.1%
    Sep 25
    Reported Oct 30
    		$2.92$2.36+23.73%Beat-18.9%
    Jun 25
    Reported Aug 7
    		$4.23$4.01+5.49%Beat+5.5%
    Mar 25
    Reported May 8
    		$3.00$2.49+20.48%Beat-0.7%
    Dec 24
    Reported Feb 13
    		$2.52$2.26+11.50%Beat-2.3%
    Sep 24
    Reported Oct 29
    		$3.60$3.11+15.76%Beat+10.8%
    Jun 24
    Reported Aug 1
    		$4.01$3.57+12.32%Beat+11.7%
    Mar 24
    Reported May 7
    		$3.02$2.25+34.22%Beat+15.7%
    Dec 23
    Reported Feb 15
    		$2.58$2.37+8.86%Beat-2.6%
    Sep 23
    Reported Nov 2
    		$3.25$3.13+3.83%Beat+9.4%
    Jun 23
    Reported Jul 27
    		$3.59$2.98+20.47%Beat+10.8%
    Mar 23
    Reported Apr 27
    		$2.61$2.16+20.83%Beat+27.3%
    Dec 22
    Reported Feb 16
    		$2.65$2.26+17.26%Beat+23.3%
    Sep 22
    Reported Nov 3
    		$2.97$2.61+13.79%Beat+20.2%
    Jun 22
    Reported Aug 4
    		$3.24$2.67+21.35%Beat+45.3%
    Mar 22
    Reported May 5
    		$2.05$1.55+32.26%Beat+37.6%
    Dec 21
    Reported Feb 16
    		$2.15$1.90+13.16%Beat+102.8%
    Sep 21
    Reported Oct 21
    		$2.47$1.86+32.80%Beat+162.8%
    Jun 21
    Reported Jul 22
    		$2.23$1.59+40.25%Beat+120.8%
    Mar 21
    Reported Apr 27
    		$1.49$0.89+67.42%Beat+577.3%
    Dec 20
    Reported Feb 23
    		$1.06$0.79+34.18%Beat+783.3%
    Sep 20
    Reported Oct 27
    		$0.94$0.70+34.29%Beat+64.9%
    Jun 20
    Reported Jul 30
    		$1.01$0.08+1162.50%Beat+71.2%
    Mar 20
    Reported Apr 23
    		$0.22$0.36-38.89%Miss-38.9%
    Dec 19
    Reported Feb 27
    		$0.12$0.08+50.00%Beat+107.0%
    Sep 19
    Reported Oct 30
    		$0.57$0.39+46.15%Beat+280.0%
    Jun 19
    Reported Aug 1
    		$0.59$0.45+31.11%Beat+11.3%
    Mar 19
    Reported May 7
    		$0.36$0.24+50.00%Beat+140.0%
    Dec 18
    Reported Feb 28
    		$-1.72$-0.24-616.67%Miss-537.0%
    Sep 18
    Reported Nov 8
    		$0.15$0.05+200.00%Beat+650.0%
    Jun 18
    Reported Aug 7
    		$0.53$0.31+70.97%Beat+130.4%
    Mar 18
    Reported May 8
    		$0.15$0.14+7.14%Beat+36.4%
    Dec 17
    Reported Feb 28
    		$-0.27$-0.33+18.18%Beat+53.4%
    Sep 17
    Reported Nov 7
    		$0.02N/A+140.00%Beat-
    Jun 17
    Reported Aug 9
    		$0.23$0.16+43.75%Beat-
    Mar 17
    Reported May 10
    		$0.11$0.03+266.67%Beat-
    Dec 16
    Reported Mar 1
    		$-0.58$-0.35-65.71%Miss-

    Key Metrics

    Valuation
    P/E Ratio9.79EV/EBITDA7.03x
    Price/FCF8.70xFCF Yield11.50%
    Profitability
    Profit Margin14.60%Operating Margin24.20%
    ROE42.30%ROIC24.40%
    Financial Health
    Debt/Equity0.94xInterest Coverage10.08x
    Current Ratio1.49xQuick Ratio0.96x
    Trading Statistics
    Beta1.56Avg Volume1.16M
    52-Week High$141.2852-Week Low$73.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$118.03
    SMA 20$120.33
    SMA 50$121.62
    SMA 200$107.75
    EMA 10$119.01
    EMA 20$119.19
    EMA 50$120.70
    EMA 200$111.75

    MACD

    Line: -0.54Signal: -0.94Hist: 0.39

    ADX

    ADX: 17.2+DI: 25.7-DI: 15.0

    Aroon & PSAR

    Aroon Up32.0
    Aroon DownN/A
    PSAR$114.08

    Bollinger Bands

    Upper Band$127.41
    Lower Band$113.24
    %B Position1178%(Upper)
    Band Width0.81

    RSI (14-Day)

    Neutral
    58.6

    Momentum Oscillators

    Stoch %K47.3
    Stoch %D30.3
    Williams %R-11.9
    ROC (10d)4.6%
    Momentum5.53
    CCI (20d)83.5
    MFI (14d)31.6

    Volatility Measures

    ATR (14d)$4.23(3.4%)
    StdDev (20d)3.54
    Hist Vol37.4%(Moderate)

    Volume Flow

    VWAP$123.99
    OBV-4.3M
    AD Line-11.2M
    CMF (20d)0.004

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.3x
    VWMA (20d)$120.61

    Pivot Points

    R3$120.70
    R2$119.37
    R1$118.45
    Pivot Point$117.12
    S1$116.20
    S2$114.87
    S3$113.95

    Advanced Oscillators

    TSI-3.64
    Ultimate Osc50.2
    KST-10.35

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.18B$921.46M$957.64M$996.30M$1.15B$937.33M$989.77M$1.06B$1.11B$938.63M$960.10M$1.05B
    Cost of Revenue$478.76M$398.51M$433.98M$413.29M$440.54M$395.78M$416.85M$428.86M$429.59M$416.56M$429.40M$464.08M
    Gross Profit$700.71M$522.95M$523.66M$583.01M$708.84M$541.55M$572.93M$633.34M$681.92M$522.08M$530.70M$581.64M
    Operating Expenses$415.03M$322.10M$377.26M$375.35M$1.14B$318.57M$373.01M$363.51M$356.18M$295.65M$321.18M$307.78M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$415.03M$322.10M$377.26M$375.35M$398.24M$318.57M$348.93M$363.51M$356.18M$295.65M$311.90M$307.78M
    Operating Income$285.68M$200.84M$146.40M$207.66M$-427,516,000$222.97M$199.91M$269.83M$325.74M$226.43M$209.51M$273.85M
    Interest Income$583,000$335,000$609,000$531,000$371,000$333,000$576,000$1.37M$1.13M$416,000$1.18M$506,000
    Interest Expense$19.91M$20.46M$21.29M$21.71M$22.52M$22.77M$23.34M$26.20M$29.16M$30.56M$36.44M$39.21M
    Income Before Tax$263.92M$178.84M$127.22M$189.43M$-448,607,000$204.94M$175.23M$244.90M$296.43M$194.03M$173.86M$233.41M
    Income Tax Expense$59.04M$41.29M$22.05M$43.61M$43.67M$44.84M$-193,675,000$45.10M$67.52M$41.58M$-79,727,000$56.38M
    Net Income$204.89M$137.56M$105.17M$145.82M$-492,282,000$160.10M$368.91M$199.80M$228.91M$152.45M$253.59M$177.03M
    EBITDA$331.82M$247.26M$196.54M$257.81M$-381,429,000$270.10M$238.87M$309.47M$362.41M$260.58M$245.56M$307.14M
    EBIT$283.25M$198.97M$147.90M$210.61M$-426,455,000$227.37M$198.00M$269.73M$324.46M$224.18M$209.12M$272.11M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CROX

    News

    Crocs (CROX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

    Crocs (CROX) experienced a -1.23% dip in its latest trading session, underperforming the S&P 500 and Nasdaq but outperforming the Dow. Despite this, its shares have increased 1.44% over the last month...

    Yahoo Finance UK•10/16/26•Neutral

    WIT Partners Advisory Pte. Ltd. Sells 242,188 Shares of Crocs, Inc. $CROX

    WIT Partners Advisory Pte. Ltd. reduced its stake in Crocs, Inc. (NASDAQ:CROX) by 27.7% in the third quarter, selling 242,188 shares, though it remains its largest holding. Despite this sale...

    MarketBeat•10/16/26•Somewhat-Bullish

    Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure

    Crocs and Liquidia stock received upgrades from analysts this week due to growth potential and resolved legal issues, respectively. In contrast...

    Yahoo Finance•10/16/26•Bullish

    Crocs sues Five Below for alleged patent, trademark infringement

    Crocs has filed a lawsuit against Five Below in the U.S. District Court for the District of Colorado, alleging trademark and patent infringement. The Broomfield-based company claims Five Below is selling "knockoff...

    KDVR•10/15/26•Bearish

    Why Crocs (CROX) Stock Is Up Today

    Shares of Crocs (NASDAQ: CROX) rose 7% after Barclays upgraded the stock to Overweight and increased its price target to $139. Analyst Adrienne Yih cited improved visibility into a broader recovery...

    FinancialContent•10/15/26•Bullish

    CROX Valuation and Fair Value

    P/E
    9.8x
    Forward P/E
    8.2x
    EV/EBITDA
    7.0x
    P/FCF
    8.7x
    PEG
    1.4x
    P/B
    4.4x
    See GNG's fair value

    CROX Profitability: Margins, ROIC and FCF

    Gross margin
    57.5%
    Operating margin
    24.2%
    Net margin
    14.6%
    ROIC
    24.4%
    ROE
    42.3%
    FCF margin
    17.4%
    FCF yield
    11.5%

    CROX Competitors

    CompanyTicker
    Lear CorporationLEA
    Caesars Entertainment CorporationCZR
    CAVA Group, Inc.CAVA
    Birkenstock Holding plcBIRK
    Lithia Motors IncLAD
    H&R Block IncHRB
    Sealed Air CorporationSEE
    The Cheesecake FactoryCAKE

    Sector: Consumer Cyclical

    CROX Analyst Ratings

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    2
    Buy
    5
    Hold
    7
    Sell
    1
    Strong Sell
    0

    CROX Bull Case vs Bear Case

    Bull case

    • CROX earns a 24.4% return on invested capital.
    • CROX converts 17.4% of revenue into free cash flow.
    • CROX beat EPS estimates in 100.0% of its last 8 reported quarters.

    CROX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    13.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $3.30
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 13 down

    Frequently Asked Questions About CROX

    Does CROX pay dividends?

    Crocs Inc (CROX) does not currently pay a regular dividend.

    What is CROX's P/E ratio?

    Crocs Inc has a price-to-earnings (P/E) ratio of 9.79.

    What is CROX's market cap?

    Crocs Inc (CROX) has a market capitalization of $5.98B with a current stock price of $124.77.

    Related stocks

    Sector: Consumer Cyclical

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In